Pamela Berry

Stapled α−helical peptide drug development: A potent dual inhibitor of MDM2 and MDMX for p53-dependent cancer therapy

Yong S. Chang, Bradford Graves, Vincent Guerlavais et al. · Proceedings of the National Academy of Sciences · 2013 · 653 citations · Full text

3-Amido Pyrrolopyrazine JAK Kinase Inhibitors: Development of a JAK3 vs JAK1 Selective Inhibitor and Evaluation in Cellular and in Vivo Models

Michael Soth, Johannes C. Hermann, Calvin Yee et al. · Journal of Medicinal Chemistry · 2012 · 66 citations · Full text

Drug Target, Janus Kinases, Immunology +21

Benzoxaborole Antimalarial Agents. Part 5. Lead Optimization of Novel Amide Pyrazinyloxy Benzoxaboroles and Identification of a Preclinical Candidate

Yong-Kang Zhang, Jacob J. Plattner, Eric E. Easom et al. · Journal of Medicinal Chemistry · 2017 · 61 citations

Combinatorial Chemistry, Antiparasitic Agent, Malaria +18

Identification of a potent benzoxaborole drug candidate for treating cryptosporidiosis

Christopher S. Lunde, Erin E. Stebbins, Rajiv S. Jumani et al. · Nature Communications · 2019 · 59 citations · Full text

Identification of a 4-fluorobenzyl l-valinate amide benzoxaborole (AN11736) as a potential development candidate for the treatment of Animal African Trypanosomiasis (AAT)

Tsutomu Akama, Yong-Kang Zhang, Yvonne R. Freund et al. · Bioorganic & Medicinal Chemistry Letters · 2017 · 45 citations · Full text